Enzene Biosciences, a subsidiary of Mumbai-India, based Alkem Laboratories, has announced the inauguration of its cutting-edge research and development (R&D) facility in Pune.

Enzene, a leading biopharmaceutical company offering integrated Contract Development and Manufacturing (CDMO) services for Biologics, has opened a new R&D facility spanning over 75,000 square feet, and is equipped with an open lab set-up that promotes cross-departmental collaboration, efficient communication, and knowledge sharing.

The facility showcases Enzene's dedication to advancing scientific research and development, offering fully integrated services from Cell Line Development to Fill & Finish across a wide range of modalities. Within the new R&D facility, Enzene has established specialised departments, including Cell Line Engineering (CLE), Drug Product Development (DPD), Purification Process Development (PPD), Advanced Analytical Technology (AAT), and Bioanalytical Assay.

These departments bring together a team of highly skilled scientists and researchers with affiliations to esteemed institutions like Massachusetts Institute of Technology, University of Tennessee Medical Centre among others and prior experience at globally renowned companies.

Enzene aims to further strengthen its partnership with CDMO clients by providing them with access to cutting-edge technologies and an extended portfolio of services. In terms of drug development continuum, Enzene will soon start offering biologics discovery services to its partners.